Nifty

:

22570.35

Sensex

:

74339.44

167.95 (0.75%)
486.50 (0.66%)

Login

Nifty
Sensex

:
:

22570.35
74339.44

167.95 (0.75%)
486.50 (0.66%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

45/99

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

124.95

25-Apr-2024

Open
High
Low
Previous Close

126.05
126.50
124.00
126.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

430051
538.53
155.50
70.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,109.78
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,469.99
N/A
4.90

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.05
6.45
1.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-3.33
-37.45
-43.62

PAT CAGR (%)

10 Years
5 Years
3 Years

0.93
-
-

P:E (Median)

8 Years
5 Years
3 Years

29.45
42.23
58.71

P:BV (Average)

8 Years
5 Years
3 Years

3.86
4.45
4.78

EV:EBITDA (Average)

8 Years
5 Years
3 Years

45.65
53.98
78.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 42.20 57.00 -25.96% 49.12 54.23 -9.42% 40.42 64.86 -37.68% 46.59 63.67 -26.83%
Expenses 46.36 65.75 -29.49% 56.82 63.81 -10.95% 49.49 66.85 -25.97% 52.64 58.46 -9.96%
EBITDA -4.16 -8.75 - -7.70 -9.58 - -9.07 -1.99 - -6.05 5.21 -
EBIDTM -9.85% -15.34% -15.68% -141.38% -22.43% -3.07% -12.97% 8.19%
Other Income 13.44 7.62 76.38% 9.87 6.73 46.66% 9.70 5.88 64.97% 8.01 5.77 38.82%
Interest 1.15 0.72 59.72% 1.21 0.57 112.28% 0.98 0.35 180.00% 0.87 0.61 42.62%
Depreciation 2.05 2.15 -4.65% 2.35 2.25 4.44% 2.42 2.38 1.68% 2.33 2.34 -0.43%
PBT 6.09 -3.99 - -1.40 -5.68 - -9.03 1.16 - -1.23 8.04 -
Tax 1.51 -2.77 - -0.48 -1.63 - -2.23 0.32 - 0.42 1.39 -69.78%
PAT 4.58 -1.23 - -0.92 -4.05 - -6.80 0.84 - -1.65 6.65 -
PATM 10.85% -2.15% -1.87% 56.25% -16.83% 1.30% -3.53% 10.44%
EPS 0.18 -0.05 - -0.04 -0.16 - -0.27 0.03 - -0.07 0.27 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 329.36 375.31 -12.24% 345.97 337.61 2.48% 333.21 341.32 -2.38% 366.67 383.71 -4.44%
Expenses 307.11 364.98 -15.86% 330.84 334.74 -1.17% 341.44 339.21 0.66% 370.04 350.36 5.62%
EBITDA 22.25 10.34 115.18% 15.13 2.87 427.18% -8.24 2.12 - -3.37 33.35 -
EBIDTM 6.76% 2.75% 4.37% -4.88% -2.47% 0.62% -0.92% 8.69%
Other Income 4.52 2.86 58.04% 1.65 0.91 81.32% 0.79 0.88 -10.23% 1.74 3.77 -53.85%
Interest 12.58 9.72 29.42% 12.58 8.12 54.93% 10.48 6.80 54.12% 10.87 6.04 79.97%
Depreciation 15.46 13.67 13.09% 15.36 13.38 14.80% 14.24 13.93 2.23% 14.71 12.93 13.77%
PBT 1.49 -10.20 - -3.09 -17.72 - -55.68 -20.93 - -88.80 18.15 -
Tax -9.18 -0.42 - 3.79 -13.28 - -21.00 -5.61 - 3.64 8.25 -55.88%
PAT 10.68 -9.78 - -6.88 -4.44 - -34.68 -15.32 - -92.44 9.90 -
PATM 3.24% -2.61% -1.99% -10.84% -10.41% -4.49% -25.21% 2.58%
EPS 0.33 -0.36 - -0.34 -0.96 - -1.40 -0.60 - -3.75 0.36 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 178.33 222.69 219.63 265.46 227.33 166.26 271.20 105.87 394.59 444.82 445.08 Net Sales Growth -25.62% 1.39% -17.26% 16.77% 36.73% -38.69% 156.16% -73.17% -11.29% -0.06% Cost Of Goods Sold 112.68 135.92 108.66 108.87 113.04 94.62 161.37 72.47 218.33 229.86 245.55 Gross Profit 65.65 86.77 110.97 156.59 114.29 71.64 109.83 33.40 176.26 214.95 199.53 GP Margin 36.81% 38.96% 50.53% 58.99% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% 44.83% Total Expenditure 205.31 249.09 231.59 241.50 205.10 163.57 258.06 121.27 359.06 384.54 437.81 Power & Fuel Cost - 13.93 11.96 12.77 12.73 8.52 2.32 2.14 17.98 20.68 21.77 % Of Sales - 6.26% 5.45% 4.81% 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% 4.89% Employee Cost - 36.66 27.38 22.42 17.10 10.71 25.12 17.90 38.84 45.47 42.87 % Of Sales - 16.46% 12.47% 8.45% 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% 9.63% Manufacturing Exp. - 39.30 48.21 58.70 51.52 41.13 15.87 14.85 56.50 48.54 49.63 % Of Sales - 17.65% 21.95% 22.11% 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% 11.15% General & Admin Exp. - 15.10 16.29 15.28 6.90 7.15 13.02 9.92 15.19 23.99 41.71 % Of Sales - 6.78% 7.42% 5.76% 3.04% 4.30% 4.80% 9.37% 3.85% 5.39% 9.37% Selling & Distn. Exp. - 1.85 2.16 4.02 2.11 1.04 0.83 0.47 4.03 5.71 7.90 % Of Sales - 0.83% 0.98% 1.51% 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% 1.77% Miscellaneous Exp. - 6.34 16.94 19.45 1.68 0.40 39.53 3.53 8.19 10.29 7.90 % Of Sales - 2.85% 7.71% 7.33% 0.74% 0.24% 14.58% 3.33% 2.08% 2.31% 6.37% EBITDA -26.98 -26.40 -11.96 23.96 22.23 2.69 13.14 -15.40 35.53 60.28 7.27 EBITDA Margin -15.13% -11.86% -5.45% 9.03% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% 1.63% Other Income 41.02 28.29 38.86 31.30 14.56 13.96 24.67 19.07 15.55 3.56 5.25 Interest 4.21 2.51 1.61 2.68 5.04 3.22 4.54 0.42 16.44 47.46 38.74 Depreciation 9.15 9.12 9.59 9.13 8.95 7.22 14.37 3.25 24.18 26.38 27.13 PBT -5.57 -9.75 15.69 43.45 22.81 6.20 18.90 -0.01 10.46 -9.99 -53.34 Tax -0.78 -3.67 0.89 8.77 1.47 -1.38 2.87 0.00 0.07 1.70 0.00 Tax Rate 14.00% 37.64% 5.67% 21.45% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% 0.00% PAT -4.79 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 PAT before Minority Interest -4.79 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 -114.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -2.69% -2.73% 6.74% 12.10% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% -25.71% PAT Growth -316.74% - -53.91% 50.47% 181.16% -98.13% - - -74.85% - EPS -0.19 -0.24 0.59 1.29 0.86 0.30 16.30 0.00 0.42 1.66 -4.59

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,375.21 1,420.91 1,412.82 1,361.62 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 455.46 Net Sales Growth -4.36% 0.57% 3.76% 15.47% 13.46% 0.85% 50.77% 9.37% 34.30% 2.17% Cost Of Goods Sold 786.97 833.77 793.00 694.65 605.05 543.01 554.23 356.70 311.71 240.72 243.65 Gross Profit 588.24 587.14 619.82 666.96 574.19 496.30 476.36 326.87 313.27 224.65 211.81 GP Margin 42.77% 41.32% 43.87% 48.98% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% 46.50% Total Expenditure 1,349.43 1,408.95 1,303.43 1,151.68 1,008.92 914.37 919.10 643.03 568.27 444.87 438.68 Power & Fuel Cost - 42.45 33.86 28.75 24.73 23.06 14.66 12.77 26.51 23.32 22.06 % Of Sales - 2.99% 2.40% 2.11% 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% 4.84% Employee Cost - 258.38 231.37 187.22 165.06 145.95 132.07 106.22 88.62 62.39 48.12 % Of Sales - 18.18% 16.38% 13.75% 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% 10.57% Manufacturing Exp. - 85.14 93.67 96.18 83.24 77.73 59.07 57.63 72.14 54.31 52.30 % Of Sales - 5.99% 6.63% 7.06% 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% 11.48% General & Admin Exp. - 75.80 66.90 58.40 56.37 58.35 70.92 48.60 36.44 33.79 43.58 % Of Sales - 5.33% 4.74% 4.29% 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% 9.57% Selling & Distn. Exp. - 58.00 57.11 50.00 45.16 36.29 36.87 28.78 17.46 20.27 12.30 % Of Sales - 4.08% 4.04% 3.67% 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% 2.70% Miscellaneous Exp. - 55.42 27.52 36.47 29.32 29.98 51.29 32.34 15.40 10.07 12.30 % Of Sales - 3.90% 1.95% 2.68% 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% 3.66% EBITDA 25.77 11.96 109.39 209.94 170.32 124.94 111.49 40.54 56.71 20.49 16.78 EBITDA Margin 1.87% 0.84% 7.74% 15.42% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% 3.68% Other Income 8.70 6.39 10.86 10.49 10.09 8.67 17.20 11.08 14.30 9.96 3.84 Interest 46.51 35.52 15.77 24.38 35.71 32.80 39.70 28.34 38.56 44.37 39.04 Depreciation 59.77 55.69 51.54 50.60 50.62 41.92 53.30 40.07 46.22 32.94 32.60 PBT -146.08 -72.86 52.93 145.45 94.08 58.88 35.70 -16.80 -13.77 -46.85 -51.00 Tax -22.75 -15.68 8.17 32.18 12.03 2.01 13.46 -0.41 2.62 3.39 0.58 Tax Rate 15.57% 11.39% 15.44% 23.55% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% -0.53% PAT -123.32 -121.16 40.95 95.44 69.91 48.66 421.57 -13.83 -18.47 -10.74 -110.49 PAT before Minority Interest -128.53 -121.98 44.76 104.45 82.05 56.88 430.83 -16.39 -16.39 -11.76 -110.49 Minority Interest -5.21 0.82 -3.81 -9.01 -12.14 -8.22 -9.26 2.56 -2.08 1.02 0.00 PAT Margin -8.97% -8.53% 2.90% 7.01% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% -24.26% PAT Growth 0.00% - -57.09% 36.52% 43.67% -88.46% - - - - EPS -4.94 -4.86 1.64 3.83 2.80 1.95 16.90 -0.55 -0.74 -0.43 -4.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,058.36 1,041.09 1,029.51 886.22 917.79 948.62 1,257.33 1,205.88 156.92 50.25 Share Capital 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 Total Reserves 952.25 944.32 972.07 822.45 849.53 882.29 1,193.03 1,134.19 92.50 11.15 Non-Current Liabilities 12.44 19.26 4.80 11.50 36.20 19.01 38.28 42.08 79.95 109.66 Secured Loans 0.00 0.00 0.00 15.16 20.61 0.00 13.98 23.82 56.70 90.47 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35 0.56 Long Term Provisions 24.40 24.51 6.59 4.09 22.30 24.39 28.88 22.84 22.97 18.70 Current Liabilities 70.24 89.56 96.62 105.24 79.87 26.69 168.71 109.89 427.45 414.42 Trade Payables 36.71 57.56 58.75 64.34 52.60 24.56 69.96 73.64 69.81 135.38 Other Current Liabilities 4.67 5.20 2.85 9.30 6.01 1.91 35.29 20.85 86.85 31.38 Short Term Borrowings 19.10 15.50 5.22 14.39 19.27 0.00 63.22 15.04 270.29 241.08 Short Term Provisions 9.77 11.30 29.81 17.22 1.99 0.21 0.24 0.36 0.51 6.58 Total Liabilities 1,141.04 1,149.91 1,130.93 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 574.33 Net Block 56.72 66.90 65.78 69.41 52.42 23.68 181.67 169.60 200.88 219.93 Gross Block 110.96 113.09 102.86 99.30 73.33 37.61 230.34 193.00 302.01 338.33 Accumulated Depreciation 54.24 46.19 37.08 29.89 20.90 13.93 48.67 23.40 101.13 118.40 Non Current Assets 1,047.29 995.04 985.95 879.01 946.46 853.77 1,095.85 1,056.39 421.95 333.95 Capital Work in Progress 2.20 1.40 4.34 3.72 0.03 3.12 32.26 19.97 8.93 11.12 Non Current Investment 632.47 658.47 685.11 738.95 788.16 672.67 834.62 834.87 183.11 65.04 Long Term Loans & Adv. 355.34 267.65 230.43 65.53 83.27 138.79 26.79 23.08 26.30 36.20 Other Non Current Assets 0.56 0.61 0.29 1.39 22.57 15.51 20.52 8.86 2.73 1.66 Current Assets 83.66 154.86 144.99 123.95 87.41 140.54 368.46 301.47 242.38 240.38 Current Investments 0.05 0.14 0.07 18.75 0.10 13.98 62.28 62.29 0.08 0.08 Inventories 47.95 67.99 45.79 31.42 25.33 13.83 62.53 56.19 66.88 101.25 Sundry Debtors 13.65 52.42 61.44 40.79 42.90 78.47 113.03 73.75 98.77 79.66 Cash & Bank 0.18 12.89 0.74 3.72 1.88 3.04 3.06 4.80 27.38 19.13 Other Current Assets 21.84 1.74 3.56 3.61 17.21 31.22 127.56 104.45 49.28 40.26 Short Term Loans & Adv. 20.84 19.69 33.40 25.66 15.65 30.09 114.68 86.38 30.28 36.32 Net Current Assets 13.42 65.31 48.37 18.71 7.54 113.85 199.75 191.58 -185.08 -174.04 Total Assets 1,130.95 1,149.90 1,130.94 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33 574.33

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 698.78 692.10 727.65 687.10 706.69 647.58 976.79 945.71 91.27 56.73 Share Capital 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 26.74 Total Reserves 592.57 595.33 670.21 623.34 638.43 581.25 912.49 874.01 26.85 -0.37 Non-Current Liabilities 258.11 209.11 153.58 216.46 214.75 227.13 246.20 299.72 277.55 159.23 Secured Loans 127.17 87.25 62.52 108.88 126.94 85.14 141.76 197.50 249.97 150.52 Unsecured Loans 55.63 35.21 31.18 41.18 20.90 18.40 23.38 13.82 0.35 0.56 Long Term Provisions 71.08 55.95 27.19 13.16 30.50 28.54 34.76 28.66 25.70 8.03 Current Liabilities 558.75 537.35 513.11 514.86 440.41 430.93 663.55 290.37 406.09 405.28 Trade Payables 244.34 258.05 226.91 220.38 209.35 160.49 203.04 143.94 90.94 114.59 Other Current Liabilities 76.88 78.99 100.64 104.98 87.80 106.52 259.26 83.23 107.43 56.80 Short Term Borrowings 182.09 159.54 102.91 147.12 127.36 152.41 194.70 56.04 204.31 226.60 Short Term Provisions 55.45 40.77 82.66 42.38 15.90 11.51 6.54 7.17 3.42 7.29 Total Liabilities 1,566.05 1,486.57 1,443.00 1,463.16 1,402.10 1,342.62 1,903.76 1,538.02 921.84 625.82 Net Block 605.31 564.44 535.66 576.57 498.14 475.97 684.33 586.48 474.43 237.59 Gross Block 939.83 825.09 753.25 762.46 638.06 581.74 789.60 643.70 596.25 369.07 Accumulated Depreciation 334.52 260.64 217.60 185.89 139.91 105.77 105.27 57.22 121.82 131.48 Non Current Assets 743.48 678.16 676.33 738.86 795.99 804.61 1,176.02 1,047.48 612.00 359.87 Capital Work in Progress 55.28 11.63 30.79 13.42 22.61 18.04 32.55 23.52 39.06 43.04 Non Current Investment 0.01 36.79 76.94 131.29 179.65 221.73 363.97 360.58 58.04 0.04 Long Term Loans & Adv. 71.34 53.92 32.15 14.40 32.27 31.01 37.51 30.35 36.01 76.06 Other Non Current Assets 11.54 11.37 0.79 3.18 63.31 57.86 57.66 46.54 4.47 3.15 Current Assets 812.48 808.41 766.68 724.30 606.12 538.01 727.74 490.54 309.84 265.94 Current Investments 0.05 1.44 5.66 40.18 0.47 17.34 64.12 66.98 0.58 0.08 Inventories 346.09 347.97 264.36 219.42 200.10 158.57 160.81 135.08 94.36 101.40 Sundry Debtors 340.96 329.24 346.14 318.76 278.25 258.35 254.62 192.39 115.44 83.54 Cash & Bank 41.75 59.25 56.20 75.83 72.04 42.45 47.40 25.30 38.46 36.21 Other Current Assets 83.64 7.68 16.82 14.79 55.26 61.30 200.79 70.80 61.01 44.71 Short Term Loans & Adv. 75.90 62.83 77.52 55.33 46.75 56.05 54.48 46.69 41.86 37.47 Net Current Assets 253.73 271.06 253.57 209.44 165.71 107.08 64.19 200.17 -96.25 -139.34 Total Assets 1,555.96 1,486.57 1,443.01 1,463.16 1,402.11 1,342.62 1,903.76 1,538.02 921.84 625.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 37.75 9.36 2.34 30.20 73.80 -4.02 -24.04 100.02 -24.99 -42.37 PBT -9.75 15.69 43.45 22.81 6.20 409.27 -0.01 10.46 43.01 -114.42 Adjustment -0.49 -6.38 1.12 1.74 -2.19 -392.74 20.30 33.58 22.54 136.20 Changes in Working Capital 48.68 1.81 -25.47 7.84 70.32 -21.10 -42.97 56.92 -89.22 -63.80 Cash after chg. in Working capital 38.45 11.12 19.09 32.39 74.34 -4.57 -22.68 100.95 -23.68 -42.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.70 -1.75 -16.76 -2.19 -0.54 0.55 -1.36 -0.93 -1.31 -0.35 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -50.70 -4.25 16.55 -17.68 -114.06 15.60 -46.84 -359.41 23.65 -60.82 Net Fixed Assets 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 Net Investments 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 Others -78.12 -23.53 -51.79 -18.58 20.18 -416.52 2.53 256.59 103.21 -23.83 Cash from Financing Activity 0.24 7.25 -21.33 -10.71 40.34 -11.78 70.97 247.38 7.96 107.56 Net Cash Inflow / Outflow -12.71 12.36 -2.44 1.81 0.07 -0.19 0.09 -12.01 6.62 4.37 Opening Cash & Equivalents 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.11 6.48 2.11 Closing Cash & Equivalent 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.10 6.48

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 16.81 30.59 114.75 115.33 116.02 45.24 -7.19 -0.05 -23.55 -44.78 PBT -137.66 52.93 145.45 94.08 58.88 445.79 -16.80 -13.77 -8.37 -109.91 Adjustment 220.72 93.73 83.98 91.41 84.47 -313.85 123.31 83.81 35.92 133.52 Changes in Working Capital -51.61 -89.30 -70.89 -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 -67.45 Cash after chg. in Working capital 31.45 57.36 158.55 127.18 115.40 54.06 2.14 -1.42 -26.44 -43.84 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.64 -26.77 -43.79 -11.85 0.62 -8.83 -9.33 1.37 2.89 -0.95 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -64.96 -95.57 9.65 -72.27 -67.69 7.17 -116.18 -315.83 -154.69 -79.95 Net Fixed Assets 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 -26.62 Net Investments 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 -10.37 Others -92.38 -114.85 -58.69 -73.17 66.55 -424.95 -66.81 300.17 -75.13 -42.96 Cash from Financing Activity 32.23 67.26 -138.75 -42.75 -20.08 -56.96 147.44 308.69 179.41 145.54 Net Cash Inflow / Outflow -15.92 2.29 -14.35 0.31 28.25 -4.55 24.07 -7.19 1.17 20.80 Opening Cash & Equivalents 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.85 22.96 3.45 Closing Cash & Equivalent 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.83 22.96

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 40.18 40.02 41.14 35.11 36.41 38.20 50.95 49.61 8.07 2.83 ROA -0.53% 1.30% 3.01% 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% -20.48% ROE -0.61% 1.47% 3.39% 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% -168.93% ROCE -0.68% 1.65% 4.45% 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% -19.54% Fixed Asset Turnover 2.01 2.04 2.66 2.66 3.00 2.05 0.52 1.65 1.45 1.45 Receivable days 53.54 94.31 69.43 66.55 132.93 127.17 310.76 77.04 70.28 58.94 Inventory Days 93.97 94.25 52.44 45.13 42.89 50.71 197.54 54.96 66.23 72.35 Payable days 126.58 195.35 206.34 103.60 86.82 78.05 239.99 74.47 102.24 128.36 Cash Conversion Cycle 20.93 -6.79 -84.46 8.08 88.99 99.83 268.31 57.53 34.27 2.92 Total Debt/Equity 0.02 0.02 0.01 0.04 0.05 0.00 0.07 0.04 2.77 9.23 Interest Cover -2.88 10.75 16.26 5.53 2.93 91.09 0.97 1.64 1.91 -1.95

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 25.76 25.97 28.98 27.10 27.86 25.85 39.44 38.69 3.76 1.97 ROA -7.99% 3.06% 7.19% 5.73% 4.14% 26.54% -0.95% -1.33% -1.52% -18.19% ROE -18.95% 6.56% 15.00% 12.06% 8.63% 54.15% -1.74% -3.35% -28.10% -201.83% ROCE -9.71% 7.01% 16.24% 12.59% 9.24% 41.28% 0.87% 2.72% 6.93% -16.09% Fixed Asset Turnover 1.65 1.83 1.80 1.72 1.74 1.51 0.96 1.03 1.01 1.36 Receivable days 84.11 85.48 89.12 90.45 92.53 90.49 118.40 87.75 74.80 57.30 Inventory Days 87.10 77.50 64.84 63.56 61.85 56.34 78.37 65.41 73.58 71.75 Payable days 109.97 111.61 117.51 80.72 75.36 77.04 104.11 77.28 87.31 115.68 Cash Conversion Cycle 61.25 51.38 36.45 73.29 79.02 69.78 92.66 75.87 61.07 13.36 Total Debt/Equity 0.62 0.49 0.31 0.51 0.47 0.48 0.43 0.34 8.26 15.86 Interest Cover -2.88 4.36 6.60 3.63 2.80 12.19 0.41 0.64 0.81 -1.82

Top Investors:

quant mutual fund - quant small cap fund

unit trust of india investment advisory services l

ashoka whiteoak icav - ashoka whiteoak india oppor

public sector pension investment board - iifl asse

investor education and protection fund (iepf)

Annual Reports:

News Update:

Sequent Scientific - Quarterly Results
13th Feb 2024, 20:53 PM

Read More
Sequent Scientific to sell plot located in Ambernath Industrial Area
8th Feb 2024, 18:19 PM

The company has executed Deed of assignment on February 08, 2024
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback